PROVAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Proval, and what generic alternatives are available?
Proval is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in PROVAL is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proval
A generic version of PROVAL was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
Summary for PROVAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROVAL at DailyMed |
US Patents and Regulatory Information for PROVAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | PROVAL #3 | acetaminophen; codeine phosphate | CAPSULE;ORAL | 085685-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |